MRSA tailors virulence mechanisms to the hospital setting

(Medical Xpress) -- In the hospital environment where antibiotic usage is extremely high, it seems that healthcare associated methicillin resistant Staphylococcus aureus (MRSA) has cleverly adapted for survival.

The findings of new research by UCD scientists led by Conway Fellow, Dr Jim O’Gara from UCD School of Biomolecular & Biomedical Science indicate that the so-called ‘super-bug’, MRSA sacrifices virulence potential for antibiotic resistance.

When the pathogen Staphylococcus aureus becomes resistant to methicillin, it also alters the way in which it produces a biofilm. This coating by colonies of the pathogen can form on prosthetic devices implanted in patients for diagnostic or therapeutic reasons and cause infection.

Patients with implanted devices are typically in an intensive care setting in hospital and have lowered immunity. They are more susceptible to infection even from a less virulent MRSA.

Describing the study that was published earlier this month in PLoS Pathogens, Dr O’Gara said, “We introduced a methicillin resistance gene into pre-clinical isolates of S. aureus in the laboratory to produce a high level resistant form of the pathogen.

We worked with Professor Brendan Loftus in the UCD Conway Genomics Core to identify the genetic changes in this modified strain of the pathogen using whole genome sequencing. These genetic changes led to biofilm development being mediated through an alternate pathway while also causing significantly reduced virulence in a murine model of device infection.”

The findings indicate that has honed its arsenal of virulence mechanisms to suit the hospital environment favouring antibiotic resistant over virulence while retaining its biofilm forming capacity and using implanted medical devices in immune-compromised patients as the optimum route to infection.

Device associated infections are difficult to treat and also necessitate the removal of the device, which in itself is not a trivial procedure for the patient. Understanding the ways by which biofilms are produced is the initial challenge to developing therapeutics to treat staphylococcal biofilm infections.

This research funded the Health Research Board, IRCSET and Healthcare Infection Society (UK) was carried out in collaboration with research groups in the University of Bath, University of Nebraska Medical Centre and Harvard Medical School.

add to favorites email to friend print save as pdf

Related Stories

MRSA head and neck infections increase among children

Jan 19, 2009

Rates of antibiotic-resistant head and neck infections increased in pediatric patients nationwide between 2001 and 2006, according to a report in the January issue of Archives of Otolaryngology-Head & Neck Surgery, one of ...

Blue light destroys antibiotic-resistant staph infection

Jan 29, 2009

Two common strains of methicillin-resistant Staphylococcus aureus, commonly known as MRSA, were virtually eradicated in the laboratory by exposing them to a wavelength of blue light, in a process called photo-irradiation that i ...

Researchers find link to severe Staph infections

Dec 23, 2008

Researchers at The University of Texas School of Public Health recently described studies that support the link between the severity of community-acquired antibiotic-resistant Staphylococcus aureus (CA MRSA) infections and th ...

Recommended for you

US looking past Ebola to prepare for next outbreak

3 hours ago

The next Ebola or the next SARS. Maybe even the next HIV. Even before the Ebola epidemic in West Africa is brought under control, U.S. public health officials are girding for the next health disaster.

Can robots help stop the Ebola outbreak?

12 hours ago

The US military has enlisted a new germ-killing weapon in the fight against Ebola—a four-wheeled robot that can disinfect a room in minutes with pulses of ultraviolet light.

New bird flu case in Germany

12 hours ago

A worrying new strain of bird flu has been observed for the first time in a wild bird in northern Germany, the agriculture ministry said Saturday.

Mali announces new Ebola case

Nov 22, 2014

Mali announced Saturday a new case of Ebola in a man who is fighting for his life in an intensive care unit in the capital Bamako.

Plague outbreak kills 40 in Madagascar: WHO

Nov 22, 2014

An outbreak of plague has killed 40 people in Madagascar, the World Health Organization said, warning that the disease could spread rapidly in the country's densely populated capital Antananarivo.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.